Treatment of Severe Henoch-Schoenlein Purpura Nephritis in Children = 소아의 심한 헤노흐-쇤라인 자반증의 치료

다국어 초록 (Multilingual Abstract)

The overall prognosis of Henoch-Schoenlein purpura (HSP) is favorable, but severe nephritis has a high risk of progression to end stage renal failure. Recent studies emphasize the importance of early treatment in children with severe HSP nephritis, but the treatment of severe HSP nephritis still remains controversial due to the rarity of randomized controlled studies in this field. Nevertheless, several intensive therapies, such as intravenous high-dose methylprednisolone pulse, immunosuppressive/cytotoxic drugs, fibrinolytic therapy, anticoagulants, antiplatelet agent and plasma exchange, have been used in children with severe HSP nephritis. In this review, we focus on the treatment of severe HSP nephritis in children.

참고문헌 (Reference)

1 Flynn JT, "Treatment of Henoch-Schönlein Purpura glomerulonephritis in children with high-dose corticosteroids plus oral cyclophosphamide" 21 : 128-133, 2001

2 Yamamoto-Shuda Y, "Therapeutic effect of glucocorticoid on experimental crescentic glomerulonephritis" 134 : 410-418, 1999

3 Oner A, "The effect of triple therapy on rapidly progressive type of Henoch-Schönlein nephritis" 9 : 6-10, 1995

4 Ronkainen J, "The adult kidney 24 years after childhood Henoch-Schönlein purpura in A retrospective cohort study" 360 : 666-670, 2002

5 Shin JI, "Successful use of cyclosporin A in severe Schönlein-Henoch nephritis resistant to both methylprednisolone pulse and azathioprine" 25 : 759-760, 2006

6 Singh S, "Severe Henoch-Schönlein nephritis: resolution with azathioprine and steroids" 22 : 133-137, 2002

7 Shin JI, "Serum IgA/C3 ratio may be a useful marker of disease activity in severe Henoch-Schönlein nephritis" 101 : c72-78, 2005

8 Rostoker G, "Schönlein-henoch purpura in children and adults: diagnosis, pathophysiology and management" 15 : 99-138, 2001

9 Meadow SR, "Schönlein- Henoch nephritis" 41 : 241-258, 1972

10 Shin JI, "Role of mesangial fibrinogen deposition in the pathogenesis of crescentic Henoch- Schönlein nephritis in children" 58 : 1147-1151, 2005

11 Narchi H, "Risk of long term renal impairment and duration of follow up recommended for Henoch-Schönlein purpura with normal or minimal urinary findings: a systematic review" 90 : 916-920, 2005

12 Sano H, "Risk factors of renal involvement and significant proteinuria in Henoch-Schönlein purpura" 161 : 196-201, 2002

13 Bergstein J, "Response of crescentic Henoch-Schoenlein purpura nephritis to corticosteroid and azathioprine therapy" 49 : 9-14, 1998

14 Chang WL, "Renal manifestations in Henoch- Schönlein purpura: a 10-year clinical study" 20 : 1269-1272, 2005

15 Kaku Y, "Renal involvement in Henoch-Schönlein purpura: a multivariate analysis of prognostic factors" 53 : 1755-1759, 1998

16 Algoet C, "Renal biopsy 2-9 years after Henoch-Schönlein purpura" 18 : 471-473, 2003

17 Wortmann SB, "Refractory severe intestinal vasculitis due to Henoch-Schönlein purpura: successful treatment with plasmapheresis" 95 : 622-623, 2006

18 Ruggenenti P, "Progression, remission, regression of chronic renal diseases" 357 : 1601-1608, 2001

19 Coppo R, "Predictors of outcome in Henoch-Schönlein nephritis in children and adults" 47 : 993-1003, 2006

20 Shin JI, "Predictive factors for nephritis, relapse, and significant proteinuria in childhood Henoch-Schönlein purpura" 35 : 56-60, 2006

21 Kawasaki Y, "Plasmapheresis therapy for rapidly progressive Henoch- Schönlein nephritis" 19 : 920-923, 2004

22 Hattori M, "Plasmapheresis as the sole therapy for rapidly progressive Henoch-Schönlein purpura nephritis in children" 33 : 427-433, 1999

23 Yoshikawa N, "Pathophysiology and treatment of IgA nephropathy in children" 16 : 446-457, 2001

24 Watanabe T, "Pathological improvement of IgA nephropathy and Henoch-Schönlein purpura nephritis with urokinase therapy" 38 : 622-628, 1996

25 Ronkainen J, "Outcome of Henoch-Schönlein nephritis with nephrotic-range proteinuria" 60 : 80-84, 2003

26 Iijima K, "Multiple combined therapy for severe Henoch-Schönlein nephritis in children" 12 : 244-248, 1998

27 Chan JC, "Modulating the progression in IgA nephropathy" 104 : c61-68, 2006

28 Niaudet P, "Methylprednisolone pulse therapy in the treatment of severe forms of Schönlein-Henoch nephritis" 12 : 238-243, 1998

29 Shin JI, "Methylprednisolone pulse therapy by the Tune-Mendoza protocol in a child with severe Henoch-Schönlein nephritis" 35 : 162-163, 2006

30 Dixit MP, "Managing Henoch-Schönlein purpura in children with fish oil and ACE inhibitor therapy" 9 : 381-386, 2004

31 Goldstein AR, "Long-term follow-up of childhood Henoch-Schönlein nephritis" 339 : 280-282, 1992

32 Camacho Diaz JA, "Long-term effect of angiotensin-converting inhibitors in children with proteinuria" 55 : 219-224, 2001

33 Tarshish P, "Henoch-Schönlein purpura nephritis: course of disease and efficacy of cyclophosphamide" 19 : 51-56, 2004

34 Davin J-C, "Henoch-Schönlein purpura nephritis: an update" 160 : 689-695, 2001

35 Shin JI, "Henoch-Schönlein purpura nephritis with nephrotic-range proteinuria: histological regression possibly associated with cyclosporin A and steroid treatment" 34 : 392-395, 2005

36 Koskimies O, "Henoch-Schönlein nephritis: long-term prognosis of unselected patients" 56 : 482-484, 1981

37 Rieu P, "Henoch-Schönlein nephritis in children and adults in Morphological features and clinicopathological correlations" 150 : 151-159, 1999

38 Halling SF, "Henoch Schönlein nephritis: clinical findings related to renal function and morphology" 20 : 46-51, 2005

39 Shin JI, "Factors affecting histological regression of crescentic Henoch-Schönlein nephritis in children" 21 : 54-59, 2006

40 Wyatt RJ, "Evidence-based assessment of treatment options for children with IgA nephropathies" 16 : 156-167, 2001

41 Kawasaki Y, "Efficacy of methylprednisolone and urokinase pulse therapy for severe Henoch-Schönlein nephritis" 111 : 785-789, 2003

42 Kawasaki Y, "Efficacy of methylprednisolone and urokinase pulse therapy combined with or without cyclophosphamide in severe Henoch-Schoenlein nephritis: a clinical and histopathological study" 19 : 858-864, 2004

43 Foster BJ, "Effective therapy for severe Henoch-Schönlein purpura nephritis with prednisone and azathioprine: a clinical and histopathological study" 136 : 370-375, 2000

44 Tanaka H, "Early treatment with oral immunosuppressants in severe proteinuric purpura nephritis" 18 : 347-350, 2003

45 Shin JI, "Cyclosporin A therapy for severe Henoch-Schönlein nephritis with nephrotic syndrome" 20 : 1093-1097, 2005

46 Ronkainen J, "Cyclosporin A for the treatment of severe Henoch-Schönlein glomerulonephritis" 18 : 1138-1142, 2003

47 Scharer K, "Clinical outcome of Schönlein-Henoch purpura nephritis in children" 13 : 816-823, 1999

48 Mir S, "Clinical outcome in children with Henoch-Schönlein nephritis" 22 : 64-70, 2007

49 Kawasaki Y, "Clinical and pathological features of children with Henoch- Schoenlein purpura nephritis: risk factors associated with poor prognosis" 60 : 153-160, 2003

50 Wright E, "Childhood vasculitis and plasma exchange" 166 : 145-151, 2007

51 Wen YK, "Cerebral vasculitis and intracerebral hemorrhage in Henoch-Schönlein purpura treated with plasmapheresis" 20 : 223-225, 2005

52 Shin JI, "Can azathioprine and steroids alter the progression of severe Henoch- Schönlein nephritis in children?" 20 : 1087-1092, 2005